ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
8.36
+0.36 (4.44%)
At close: Apr 24, 2026, 4:00 PM EDT
8.21
-0.14 (-1.74%)
After-hours: Apr 24, 2026, 5:01 PM EDT

ImmuCell Revenue

In the year 2025, ImmuCell had annual revenue of $27.64M with 4.34% growth. ImmuCell had revenue of $7.63M in the quarter ending December 31, 2025, a decrease of -1.61%.

Revenue (ttm)
$27.64M
Revenue Growth
+4.34%
P/S Ratio
2.73
Revenue / Employee
$378,687
Employees
73
Market Cap
75.59M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202527.64M1.15M4.34%
Dec 31, 202426.49M9.02M51.63%
Dec 31, 202317.47M-1.10M-5.90%
Dec 31, 202218.57M-675.00K-3.51%
Dec 31, 202119.24M3.90M25.43%
Dec 31, 202015.34M1.62M11.80%
Dec 31, 201913.72M2.74M24.91%
Dec 31, 201810.99M555.20K5.32%
Dec 31, 201710.43M887.14K9.30%
Dec 31, 20169.54M-684.74K-6.69%
Dec 31, 201510.23M2.63M34.64%
Dec 31, 20147.60M1.59M26.46%
Dec 31, 20136.01M617.24K11.45%
Dec 31, 20125.39M278.80K5.45%
Dec 31, 20115.11M724.94K16.53%
Dec 31, 20104.39M-119.56K-2.65%
Dec 31, 20094.51M-122.55K-2.65%
Dec 31, 20084.63M-6.21M-57.31%
Dec 31, 200710.84M1.73M19.04%
Dec 31, 20069.11M-109.26K-1.19%
Dec 31, 20059.22M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fortress Biotech63.26M
Pelthos Therapeutics16.80M
TScan Therapeutics10.33M
Immutep5.28M
aTyr Pharma190.00K
Revenue Rankings